Bram Govaerts, director general of the International Maize and Wheat Improvement Center, will kick off the A.D. White Professors-at-Large spring 2026 visits with a pair of talks addressing agri-food research and innovation.
Immunotherapy has not worked well against fibrolamellar carcinoma, but a new study finds an existing FDA-approved drug may allow the treatment to fight the cancer as intended.
Cornell Tech has appointed Tanzeem Choudhury as its Chief of Health Innovation and has formed a new Health Tech Hub Advisory Committee composed of leaders from across the healthcare industry.
Christian Gant-Madison's '25 platform will use AI to connect youth to jobs, skill development opportunities, civic education information and social resources.
The popular diabetes and weight-loss medication tirzepatide may lower the risk of diabetic retinopathy, a leading cause of vision loss, according to Weill Cornell Medicine investigators.
